As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?
The biotech breaks a cycle of widening losses as it shifts towards developing new drugs Key Takeaways: Zai Lab reported its loss shrank 65% in the first quarter of the…
RELATED ARTICLES
-
No respite for RemeGen as problems and losses pile up
9995.HK 688331.SHG
-
After 14 years of losses, Zhihu finds an answer to its profitability question
2390.HK ZH.US
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Ninja Turtles slowdown breaks Playmates two-year winning streak
0869.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- PegBio aims to bulk up its finances to deliver weight-loss drugs
Discover hidden China stock gems in our weekly newsletter